The spectrum of latent tuberculosis: rethinking the biology and intervention strategies (original) (raw)

• Comstock, G. W., Baum, C. & Snider, D. E. Jr. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am. Rev. Respir. Dis. 119, 827–830 (1979).
  CAS PubMed Google Scholar
• Dye, C. & Williams, B. G. Eliminating human tuberculosis in the twenty-first century. J. R. Soc. Interface 5, 653–662 (2008).
  Article PubMed Google Scholar
• Stead, W. W. Management of health care workers after inadvertent exposure to tuberculosis: a guide for the use of preventive therapy. Ann. Intern. Med. 122, 906–912 (1995).
  Article CAS PubMed Google Scholar
• Pai, M., Zwerling, A. & Menzies, D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med. 149, 177–184 (2008).
  Article PubMed PubMed Central Google Scholar
• Young, D. B., Gideon, H. P. & Wilkinson, R. J. Eliminating latent tuberculosis. Trends Microbiol. 17, 193–188 (2009).
  Article CAS Google Scholar
• Mtei, L. et al. High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin. Infect. Dis. 40, 1500–1507 (2005).
  Article PubMed Google Scholar
• Vandiviere, H. M., Loring, W. E., Melvin, I. & Willis, S. The treated pulmonary lesion and its tubercle bacillus. II. The death and resurrection. Am. J. Med. Sci. 232, 30–37 (1956).
  Article CAS PubMed Google Scholar
• Capuano, S. V. 3rd et al. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect. Immun. 71, 5831–5844 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Lin, P. L. et al. Early events in Mycobacterium tuberculosis infection in cynomolgus macaques. Infect. Immun. 74, 3790–3803 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Goo, J. M. et al. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology 216, 117–121 (2000).
  Article CAS PubMed Google Scholar
• Hara, T., Kosaka, N., Suzuki, T., Kudo, K. & Niino, H. Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study. Chest 124, 893–901 (2003).
  Article CAS PubMed Google Scholar
• Yang, C. M., Hsu, C. H., Lee, C. M. & Wang, F. C. Intense uptake of [F-18]-fluoro-2 deoxy-D-glucose in active pulmonary tuberculosis. Ann. Nucl. Med. 17, 407–410 (2003).
  Article PubMed Google Scholar
• Park, I. N., Ryu, J. S. & Shim, T. S. Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography. Clin. Nucl. Med. 33, 1–3 (2008).
  Article CAS PubMed Google Scholar
• Canetti, G., Parrot, R., Porven, G. & Le Lirzin, M. Rifamycin levels in the lung and tuberculous lesions in man. Acta Tuberc. Pneumol. Belg. 60, 315–322 (1969).
  CAS PubMed Google Scholar
• Kislitsyna, N. A. Comparative evaluation of rifampicin and isoniazid penetration into the pathological foci of the lungs in tuberculosis patients. Probl. Tuberk. 55–57 (1985).
• Kislitsyna, N. A. & Kotova, N. I. Rifampicin and isoniazid concentration in the blood and resected lungs in tuberculosis with combined use of the preparations. Probl. Tuberk 8, 63–65 (1980).
  Google Scholar
• Sauermann, R. et al. Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration-time profiles. Antimicrob. Agents Chemother. 49, 4448–4454 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Wagner, C., Sauermann, R. & Joukhadar, C. Principles of antibiotic penetration into abscess fluid. Pharmacology 78, 1–10 (2006).
  Article CAS PubMed Google Scholar
• Cotran, R. S., Kumar, V. & Robbins, S. L. in Pathologic Basis of Disease (ed. Company, W. B. S.) (Saunders, Philadelphia, 1989).
  Google Scholar
• Dannenberg, A. M. Jr in Pathogenesis of Human Pulmonary Tuberculosis 36–64 (ASM, Washington D. C., 2006). A comprehensive review of five decades of literature on the pathogenesis of tuberculosis in humans and in the rabbit model, including comparisons with other animal models.
  Book Google Scholar
• Via, L. E. et al. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect. Immun. 76, 2333–2340 (2008). A conclusive demonstration that hypoxia is a relevant phenotype in several non-mouse animal models of TB.
  Article CAS PubMed PubMed Central Google Scholar
• Rhoades, E. R., Frank, A. A. & Orme, I. M. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber Lung Dis. 78, 57–66 (1997).
  Article CAS PubMed Google Scholar
• Radaeva, T. V., Nikonenko, B. V., Mischenko, V. V., Averbakh, M. M. Jr & Apt, A. S. Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice. Tuberculosis (Edinb.) 85, 65–72 (2005).
  Article CAS Google Scholar
• Sissons, J. et al. Multigenic control of tuberculosis resistance: analysis of a QTL on mouse chromosome 7 and its synergism with sst1. Genes Immun. 10, 37–46 (2009).
  Article CAS PubMed Google Scholar
• Manabe, Y. C. et al. The aerosol rabbit model of TB latency, reactivation and immune reconstitution inflammatory syndrome. Tuberculosis (Edinb.) 88, 187–196 (2008).
  Article CAS Google Scholar
• Kesavan, A. K., Brooks, M., Tufariello, J., Chan, J. & Manabe, Y. C. Tuberculosis genes expressed during persistence and reactivation in the resistant rabbit model. Tuberculosis (Edinb.) 89, 17–21 (2009).
  Article CAS Google Scholar
• Tsenova, L. et al. Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J. Infect. Dis. 192, 98–106 (2005).
  Article PubMed Google Scholar
• Gandotra, S., Schnappinger, D., Monteleone, M., Hillen, W. & Ehrt, S. In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice. Nature Med. 13, 1515–1520 (2007). Demonstration of the use of conditional gene expression systems to study mycobacterial pathogenesis.
  Article CAS PubMed Google Scholar
• Sonnenberg, P. et al. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J. Infect. Dis. 191, 150–158 (2005).
  Article PubMed Google Scholar
• Keane, J. et al. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N. Engl. J. Med. 345, 1098–1104 (2001). The first demonstration that suppressing TNF levels correlates with reactivation of latent TB, the implication being that there is a delicate balance between immune function and the development of disease.
  Article CAS PubMed Google Scholar
• Marino, S. et al. Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissue. PLoS Comput. Biol. 3, 1909–1924 (2007).
  Article CAS PubMed Google Scholar
• Sud, D., Bigbee, C., Flynn, J. L. & Kirschner, D. E. Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection. J. Immunol. 176, 4296–4314 (2006).
  Article CAS PubMed Google Scholar
• Ray, J. C., Flynn, J. L. & Kirschner, D. E. Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection. J. Immunol. 182, 3706–3717 (2009). Illustrates the use of modelling to understand the complex dynamics of tuberculous granulomas.
  Article CAS PubMed Google Scholar
• Timm, J. et al. Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients. Proc. Natl Acad. Sci. USA 100, 14321–14326 (2003). This is the first study to attempt to relate the transcriptional responses in humans to conditions relevant to disease.
  Article CAS PubMed PubMed Central Google Scholar
• Fenhalls, G. et al. In situ detection of Mycobacterium tuberculosis transcripts in human lung granulomas reveals differential gene expression in necrotic lesions. Infect. Immun. 70, 6330–6338 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Xie, Z., Siddiqi, N. & Rubin, E. J. Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 49, 4778–4780 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Paramasivan, C. N., Sulochana, S., Kubendiran, G., Venkatesan, P. & Mitchison, D. A. Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49, 627–631 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Herbert, D. et al. Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 40, 2296–2299 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Wayne, L. G. & Sramek, H. A. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 38, 2054–2058 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Schnappinger, D. et al. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198, 693–704 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Rohde, K. H., Abramovitch, R. B. & Russell, D. G. Mycobacterium tuberculosis invasion of macrophages: linking bacterial gene expression to environmental cues. Cell Host Microbe 2, 352–364 (2007).
  Article CAS PubMed Google Scholar
• Tailleux, L. et al. Probing host pathogen cross-talk by transcriptional profiling of both Mycobacterium tuberculosis and infected human dendritic cells and macrophages. PLoS ONE 3, e1403 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Talaat, A. M. et al. Mycobacterial bacilli are metabolically active during chronic tuberculosis in murine lungs: insights from genome-wide transcriptional profiling. J. Bacteriol. 189, 4265–4274 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Voskuil, M. I. et al. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198, 705–713 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Rodriguez, G. M., Voskuil, M. I., Gold, B., Schoolnik, G. K. & Smith, I. ideR, an essential gene in Mycobacterium tuberculosis: role of IdeR in iron-dependent gene expression, iron metabolism, and oxidative stress response. Infect. Immun. 70, 3371–3381 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Fisher, M. A., Plikaytis, B. B. & Shinnick, T. M. Microarray analysis of the Mycobacterium tuberculosis transcriptional response to the acidic conditions found in phagosomes. J. Bacteriol. 184, 4025–4032 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Rustad, T. R., Harrell, M. I., Liao, R. & Sherman, D. R. The enduring hypoxic response of Mycobacterium tuberculosis. PLoS ONE 3, e1502 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Converse, P. J. et al. Role of the dosR-dosS two-component regulatory system in Mycobacterium tuberculosis virulence in three animal models. Infect. Immun. 77, 1230–1237 (2009).
  Article CAS PubMed Google Scholar
• Malhotra, V. et al. Disruption of response regulator gene, devR, leads to attenuation in virulence of Mycobacterium tuberculosis. FEMS Microbiol. Lett. 231, 237–245 (2004).
  Article CAS PubMed Google Scholar
• Dahl, J. L. et al. The relA homolog of Mycobacterium smegmatis affects cell appearance, viability, and gene expression. J. Bacteriol. 187, 2439–2447 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• McKinney, J. D. et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406, 735–738 (2000).
  Article CAS PubMed Google Scholar
• Munoz-Elias, E. J., Upton, A. M., Cherian, J. & McKinney, J. D. Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence. Mol. Microbiol 60, 1109–1122 (2006).
  Article CAS PubMed Google Scholar
• Rachman, H. et al. Unique transcriptome signature of Mycobacterium tuberculosis in pulmonary tuberculosis. Infect. Immun. 74, 1233–1242 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Garton, N. J. et al. Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med. 5, e75 (2008). This work raises new questions about the metabolic consequences of activation of the dormancy regulon in M. tuberculosis and the presence of lipid bodies.
  Article CAS PubMed PubMed Central Google Scholar
• Boshoff, H. I. et al. Biosynthesis and recycling of nicotinamide cofactors in Mycobacterium tuberculosis. An essential role for NAD in nonreplicating bacilli. J. Biol. Chem. 283, 19329–19341 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Sassetti, C. M. & Rubin, E. J. Genetic requirements for mycobacterial survival during infection. Proc. Natl Acad. Sci. USA 100, 12989–12994 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Beste, D. J. et al. GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism. Genome Biol. 8, R89 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Raman, K., Rajagopalan, P. & Chandra, N. Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs. PLoS Comput. Biol. 1, e46 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Bloch, H. & Segal, W. Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro. J. Bacteriol. 72, 132–141 (1956).
  CAS PubMed PubMed Central Google Scholar
• Segal, W. & Bloch, H. Pathogenic and immunogenic differentiation of Mycobacterium tuberculosis grown in vitro and in vivo. Am. Rev. Tuberc. 75, 495–500 (1957).
  CAS PubMed Google Scholar
• Lange, R. P., Locher, H. H., Wyss, P. C. & Then, R. L. The targets of currently used antibacterial agents: lessons for drug discovery. Curr. Pharm. Des 13, 3140–3154 (2007).
  Article CAS PubMed Google Scholar
• Walsh, C. in Antibiotics: Actions, Origins, Resistance 11–88 (ASM, Washington, D. C., 2003).
  Book Google Scholar
• Kohanski, M. A., Dwyer, D. J., Wierzbowski, J., Cottarel, G. & Collins, J. J. Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 135, 679–690 (2008). A must-read illustration of the complexities of the mechanism by which antibiotics cause bacteria to die.
  Article CAS PubMed PubMed Central Google Scholar
• Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A. & Collins, J. J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130, 797–810 (2007).
  Article CAS PubMed Google Scholar
• Singh, R. et al. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Science 322, 1392–1395 (2008). Identification of new mycobactericidal mechanism under anaerobic conditions.
  Article CAS PubMed PubMed Central Google Scholar
• Rao, S. P., Alonso, S., Rand, L., Dick, T. & Pethe, K. The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 105, 11945–11950 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Dhar, N. & McKinney, J. D. Microbial phenotypic heterogeneity and antibiotic tolerance. Curr. Opin. Microbiol. 10, 30–38 (2007).
  Article CAS PubMed Google Scholar
• Brehm-Stecher, B. F. & Johnson, E. A. Single-cell microbiology: tools, technologies, and applications. Microbiol. Mol. Biol. Rev. 68, 538–559 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Payne, D. J., Gwynn, M. N., Holmes, D. J. & Pompliano, D. L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nature Rev. Drug Discov. 6, 29–40 (2007). A review that describes many of the challenges complicating antibacterial drug development.
  Article CAS Google Scholar
• Silver, L. L. Multi-targeting by monotherapeutic antibacterials. Nature Rev. Drug Discov. 6, 41–55 (2007).
  Article CAS Google Scholar
• Manjunatha, U. H. et al. Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 103, 431–436 (2006).
  Article CAS PubMed Google Scholar
• Andries, K. et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307, 223–227 (2005). First report of a promising new antimycobacterial agent with activity against replicating and non-replicating cultures.
  Article CAS PubMed Google Scholar
• Terstappen, G. C., Schlupen, C., Raggiaschi, R. & Gaviraghi, G. Target deconvolution strategies in drug discovery. Nature Rev. Drug Discov. 6, 891–903 (2007).
  Article CAS Google Scholar
• Boshoff, H. I. et al. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J. Biol. Chem. 279, 40174–40184 (2004).
  Article CAS PubMed Google Scholar
• Dartois V., Leong, F. J. & Dick, T. in Antiparasitic and Antibacterial Drug Discovery: From Molecular Targets to Drug Candidates. (ed. Seltzer, P. M.) 415–440 (Wiley-VCH, Weinheim, 2009).
  Book Google Scholar
• Ciulli, A. & Abell, C. Fragment-based approaches to enzyme inhibition. Curr. Opin. Biotechnol. 18, 489–496 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Nikaido, H. & Jarlier, V. Permeability of the mycobacterial cell wall. Res. Microbiol 142, 437–443 (1991).
  Article CAS PubMed Google Scholar
• Liu, J., Barry, C. E. 3rd, Besra, G. S. & Nikaido, H. Mycolic acid structure determines the fluidity of the mycobacterial cell wall. J. Biol. Chem. 271, 29545–29551 (1996).
  Article CAS PubMed Google Scholar
• Faller, M., Niederweis, M. & Schulz, G. E. The structure of a mycobacterial outer-membrane channel. Science 303, 1189–1192 (2004).
  Article CAS PubMed Google Scholar
• Sassetti, C. M., Boyd, D. H. & Rubin, E. J. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 48, 77–84 (2003).
  Article CAS PubMed Google Scholar
• Pichota, A. et al. Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological results. Bioorg. Med. Chem. Lett. 18, 6568–6572 (2008).
  Article CAS PubMed Google Scholar
• Klotzsche, M., Ehrt, S. & Schnappinger, D. Improved tetracycline repressors for gene silencing in mycobacteria. Nucleic Acids Res. 37, 1778–1788 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ferebee, S. H. & Mount, F. W. Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts. Am. Rev. Respir. Dis. 85, 490–510 (1962).
  CAS PubMed Google Scholar
• Ferebee, S. H., Mount, F. W., Murray, F. J. & Livesay, V. T. A controlled trial of isoniazid prophylaxis in mental institutions. Am. Rev. Respir. Dis. 88, 161–175 (1963).
  CAS PubMed Google Scholar
• Wallis, R. S. et al. Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect. Dis. 9, 162–172 (2009).
  Article CAS PubMed Google Scholar
• Ewer, K. et al. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 174, 831–839 (2006).
  Article CAS PubMed Google Scholar
• Goletti, D. et al. Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study. Respir. Res. 8, 5 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Wilkinson, K. A. et al. Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. J. Infect. Dis. 193, 354–359 (2006).
  Article CAS PubMed Google Scholar
• Higuchi, K., Harada, N. & Mori, T. Interferon-γ responses after isoniazid chemotherapy for latent tuberculosis. Respirology 13, 468–472 (2008).
  Article PubMed Google Scholar
• Veening, G. J. Long term isoniazid prophylaxis. Controlled trial on INH prophylaxis after recent tuberculin conversion in young adults. Bull. Int. Union Tuberc. 41, 169–171 (1968).
  CAS PubMed Google Scholar
• Comstock, G. W. & Woolpert, S. F. in The Mycobacteria: A Sourcebook (eds Kubica, G. P. & Wayne, L. G.) 1071–1082 (Marcel Dekker, New York, 1984).
  Google Scholar
• Lin, P. L. et al. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect Immun. 77, 4631–4642 (2009).
  Article CAS PubMed PubMed Central Google Scholar